DalsnaFinance › IPOs › Acrivon Therapeutics › IPO
Acrivon Therapeutics, Inc. completed its initial public offering on NASDAQ on November 15, 2022, pricing at $12.50 a share.
| Ticker | ACRV |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | November 15, 2022 |
| Offering price | $12.50 |
| Shares offered | 7,550,000 |
| Total raised | $94M |
Acrivon Therapeutics, Inc. sold 7,550,000 shares at $12.50 each on NASDAQ. Multiplied out, that is $94.4 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $94 million total recorded for the deal.
Acrivon Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Acrivon Therapeutics, Inc.. This page is general information, not investment advice.